Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Non-Hodgkin Lymphoma (Late Stage^), 2016-2020

All Races (includes Hispanic), Female, All Ages

Sorted by Percentlate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late ascending
US (SEER+NPCR) 1 9.7 (9.6, 9.7) N/A 19,778 62.8
Maine 6 10.6 (9.7, 11.6) 11 (1, 34) 112 69.3
Wisconsin 6 11.5 (11.0, 12.0) 2 (1, 9) 449 69.1
Kentucky 3 11.3 (10.7, 11.9) 4 (1, 14) 337 68.9
West Virginia 6 11.2 (10.4, 12.1) 5 (1, 22) 149 68.8
Iowa 3 12.1 (11.5, 12.9) 1 (1, 6) 254 68.7
Colorado 6 9.2 (8.7, 9.7) 35 (21, 40) 304 68.6
Maryland 6 10.0 (9.6, 10.5) 22 (9, 34) 395 68.5
Ohio 6 10.6 (10.3, 10.9) 10 (5, 20) 843 68.3
South Dakota 6 11.4 (10.1, 12.8) 3 (1, 32) 63 68.3
North Carolina 6 9.8 (9.5, 10.2) 24 (14, 33) 673 68.0
Montana 6 9.6 (8.6, 10.7) 28 (4, 42) 71 67.5
Missouri 6 10.2 (9.8, 10.7) 16 (6, 30) 426 67.1
Utah 3 9.7 (9.0, 10.4) 27 (7, 39) 143 66.9
Idaho 3 10.1 (9.3, 11.0) 18 (3, 38) 108 66.8
Pennsylvania 6 11.1 (10.8, 11.4) 6 (2, 11) 1,020 66.6
Delaware 6 9.4 (8.4, 10.6) 31 (6, 44) 66 66.5
Kansas 6 10.1 (9.4, 10.8) 19 (5, 35) 186 65.9
Michigan 6 10.2 (9.8, 10.6) 17 (8, 28) 688 65.7
California 3 9.6 (9.4, 9.8) 29 (21, 34) 2,250 65.3
Illinois 3 10.3 (10.0, 10.6) 14 (7, 25) 846 65.3
Massachusetts 3 10.1 (9.6, 10.5) 20 (9, 32) 471 65.1
District of Columbia 6 7.5 (6.3, 8.9) 47 (30, 49) 28 65.0
Louisiana 3 10.0 (9.5, 10.6) 21 (7, 33) 296 64.9
North Dakota 6 9.9 (8.6, 11.3) 23 (1, 44) 45 64.3
Georgia 3 9.1 (8.8, 9.5) 36 (26, 40) 569 64.2
Vermont 6 9.4 (8.2, 10.8) 32 (3, 46) 45 64.2
Alaska 6 9.3 (7.9, 10.9) 34 (2, 48) 33 63.7
Nebraska 6 10.3 (9.5, 11.2) 15 (2, 36) 123 62.7
Oregon 6 9.4 (8.8, 9.9) 33 (17, 40) 259 62.7
Virginia 6 8.6 (8.3, 9.0) 39 (33, 43) 466 62.6
Arkansas 6 8.9 (8.3, 9.5) 38 (24, 43) 180 62.5
South Carolina 6 7.8 (7.4, 8.2) 43 (40, 48) 276 62.5
Alabama 6 7.7 (7.3, 8.1) 45 (41, 48) 257 62.4
Washington 5 9.8 (9.4, 10.2) 26 (13, 35) 455 62.4
Wyoming 6 8.0 (6.7, 9.5) 42 (19, 49) 29 62.4
Rhode Island 6 9.8 (8.8, 10.9) 25 (3, 41) 72 62.3
Oklahoma 6 9.1 (8.6, 9.7) 37 (21, 41) 228 61.9
Connecticut 3 10.7 (10.1, 11.3) 8 (2, 26) 268 61.5
Hawaii 3 7.6 (6.8, 8.5) 46 (37, 49) 75 61.4
Minnesota 6 10.7 (10.2, 11.2) 7 (3, 22) 386 61.4
Arizona 6 7.2 (6.8, 7.5) 48 (44, 49) 343 61.2
Tennessee 6 8.6 (8.2, 9.0) 40 (33, 43) 386 60.9
New Hampshire 6 10.5 (9.6, 11.5) 12 (1, 36) 100 60.4
New York 3 10.6 (10.4, 10.9) 9 (5, 19) 1,390 59.8
New Jersey 3 10.4 (10.0, 10.8) 13 (5, 26) 625 59.2
Mississippi 6 7.7 (7.2, 8.3) 44 (39, 48) 148 58.7
Texas 3 8.3 (8.1, 8.5) 41 (38, 44) 1,277 58.3
Florida 6 9.4 (9.2, 9.7) 30 (23, 36) 1,494 51.8
New Mexico 3 6.3 (5.7, 6.9) 49 (47, 49) 88 51.6
Puerto Rico 6 5.0 (4.5, 5.4) N/A 108 40.7
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 07/01/2024 3:40 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top